by Riley Nolan | Dec 28, 2021 | Featured, Thinking Out Loud -Blog
Happy Holidays! The EpiVax team wishes you, your colleagues, and family very safe, happy, and healthy holidays! This team is so grateful for our wonderful clients, colleagues, and friends! It has been our privilege working with all of you this year, and we look...
by Riley Nolan | Sep 10, 2021 | Events, Featured
EpiVax participated in the 2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021. The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community. Multiple EpiVax...
by Riley Nolan | Jul 6, 2021 | Featured, News
PROVIDENCE, RI, July 6, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce that Dr. Amy Rosenberg is leaving the FDA’s Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and...
by Annie De Groot | Dec 11, 2016 | EpiVax Immunoncology, Featured, News, Thinking Out Loud -Blog
Building on 18 years of commercially successful research and development in the field of computational immunology, EpiVax has now developed Ancer™, a personalized cancer vaccine platform. Ancer is a high-speed, secure, cloud-based commercial platform for processing...